Ridgeway Capital Partners
3
37M
3
0.14
1
- Stages of investment
- Areas of investment
Summary
Ridgeway Capital Partners appeared to be the VC, which was created in 2001. The company was established in Asia in Japan. The main office of represented VC is situated in the Tokyo.
The increased amount of exits for fund were in 2014. The important activity for fund was in 2008. The common things for fund are deals in the range of 50 - 100 millions dollars. The fund is generally included in less than 2 deals every year.
The typical case for the fund is to invest in rounds with 7 participants. Despite the Ridgeway Capital Partners, startups are often financed by Remeditex Ventures, AVG Ventures, James Brown. The meaningful sponsors for the fund in investment in the same round are venBio Partners, SoftBank Capital, Sabby Capital. In the next rounds fund is usually obtained by Cancer Prevention and Research Institute of Texas.
The fund has exact preference in a number of founders of portfolio startups. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline Soma Networks, Bellicum Pharmaceuticals For fund there is no match between the location of its establishment and the land of its numerous investments - United States. Among the most successful fund investment fields, there are Wireless, Infrastructure.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 0
- Exits
- 1
- Rounds per year
- 0.14
- Investments by industry
- Therapeutics (1)
- Health Care (1)
- Biotechnology (1)
- Health Diagnostics (1)
- Video (1) Show 2 more
- Investments by region
-
- United States (3)
- Peak activity year
- 2014
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 21
- Avg. valuation at time of investment
- 2M
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Bellicum Pharmaceuticals | 27 Aug 2014 | Biotechnology, Health Care, Health Diagnostics, Therapeutics | Late Stage Venture | 55M | United States, Texas, Houston |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.